Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niraj K Tripathi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Toxicologic Pathology|January 21, 2011
Response to International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et. alNiraj K Tripathi
Veterinary Clinical Pathology|June 15, 2004
Hematologic reference intervals for koi (Cyprinus carpio), including blood cell morphology, cytochemistry, and ultrastructureNiraj K Tripathi, Kenneth S Latimer, Victoria V Burnley
Veterinary Clinical Pathology|February 24, 2015
Factors affecting urine reagent strip blood results in dogs and nonhuman primates and interpretation of urinalysis in preclinical toxicology studies: a Multi-Institution Contract Research Organization and BioPharmaceutical Company PerspectiveAdam D Aulbach, Eric Schultze, Niraj K Tripathi, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|February 5, 2005
Development and evaluation of an experimental model of cutaneous columnaris disease in koi Cyprinus carpioNiraj K Tripathi, Kenneth S Latimer, Christopher R Gregory, et al.
Toxicologic Pathology|November 3, 2016
Deciphering Sources of Variability in Clinical PathologyNiraj K Tripathi, Nancy E Everds, A Eric Schultze, et al.
Toxicologic Pathology|February 17, 2016
STP Best Practices for Evaluating Clinical Pathology in Pharmaceutical Recovery StudiesLindsay Tomlinson, Lila Ramaiah, Niraj K Tripathi, et al.
Toxicologic Pathology|January 7, 2017
Principles for Assessing Adversity in Toxicologic Clinical PathologyLila Ramaiah, Lindsay Tomlinson, Niraj K Tripathi, et al.
Toxicologic Pathology|April 8, 2014
Nontraditional applications in clinical pathologyHolly L Jordan, Thomas C Register, Niraj K Tripathi, et al.
Regulatory Toxicology and Pharmacology : RTP|May 21, 2017
Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR<sup>®</sup>/ABASAGLAR<sup>®</sup>) approved in the European UnionRichard A Byrd, Rebecca A Owens, Jamie L Blackbourne, et al.
Toxicologic Pathology|March 8, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®)Anne M Ryan, Sharon A Sokolowski, Chee-Keng Ng, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Toxicologic Pathology|January 21, 2011
Response to International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et. alNiraj K Tripathi
Veterinary Clinical Pathology|June 15, 2004
Hematologic reference intervals for koi (Cyprinus carpio), including blood cell morphology, cytochemistry, and ultrastructureNiraj K Tripathi, Kenneth S Latimer, Victoria V Burnley
Veterinary Clinical Pathology|February 24, 2015
Factors affecting urine reagent strip blood results in dogs and nonhuman primates and interpretation of urinalysis in preclinical toxicology studies: a Multi-Institution Contract Research Organization and BioPharmaceutical Company PerspectiveAdam D Aulbach, Eric Schultze, Niraj K Tripathi, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|February 5, 2005
Development and evaluation of an experimental model of cutaneous columnaris disease in koi Cyprinus carpioNiraj K Tripathi, Kenneth S Latimer, Christopher R Gregory, et al.
Toxicologic Pathology|November 3, 2016
Deciphering Sources of Variability in Clinical PathologyNiraj K Tripathi, Nancy E Everds, A Eric Schultze, et al.
Toxicologic Pathology|February 17, 2016
STP Best Practices for Evaluating Clinical Pathology in Pharmaceutical Recovery StudiesLindsay Tomlinson, Lila Ramaiah, Niraj K Tripathi, et al.
Toxicologic Pathology|January 7, 2017
Principles for Assessing Adversity in Toxicologic Clinical PathologyLila Ramaiah, Lindsay Tomlinson, Niraj K Tripathi, et al.
Toxicologic Pathology|April 8, 2014
Nontraditional applications in clinical pathologyHolly L Jordan, Thomas C Register, Niraj K Tripathi, et al.
Regulatory Toxicology and Pharmacology : RTP|May 21, 2017
Nonclinical pharmacology and toxicology of the first biosimilar insulin glargine drug product (BASAGLAR<sup>®</sup>/ABASAGLAR<sup>®</sup>) approved in the European UnionRichard A Byrd, Rebecca A Owens, Jamie L Blackbourne, et al.
Toxicologic Pathology|March 8, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®)Anne M Ryan, Sharon A Sokolowski, Chee-Keng Ng, et al.
Pageof 2